FDA Late Radiation Toxicity Draft Guidance Aims To Minimize Patient Risk
Executive Summary
Nonclinical studies evaluating late radiation toxicity of radiopharmaceuticals will help identify at-risk organs and establish a margin of safety for late radiation toxicity, FDA's Center for Drug Evaluation & Research says